Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer Treatment and Pharmacology, Breast Cancer Treatment Studies, Neutropenia and Cancer Infections, and Advanced Breast Cancer Therapies.
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
Overall Survival with Fulvestrant plus Anastrozole in Metastatic Breast Cancer
Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226
Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer